ALTHOUGH CONTRACTILE AGONISTS and growth factors act through distinct categories of receptors, G protein coupled and tyrosine kinases, the effects of these two classes of stimuli may be similar. It is well established that contractile agonists may have mitogenic properties, whereas growth factors can have contractile effects. A growing number of studies conducted on several tissues, including vascular smooth muscle, have confirmed that indeed there is considerable ''cross talk'' between signaling pathways mediating contraction and those mediating growth (7, 11, 15, 17) .
Smooth muscle contraction is critically dependent on the increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ). For most contractile agonists, this increase is caused by release of Ca 2ϩ from intracellular stores, resulting from the binding of inositol 1,4,5-trisphosphate (IP 3 ) to the receptors on sarcoplasmic reticulum followed by Ca 2ϩ influx from the extracellular milieu. IP 3 , in turn, is produced by a rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate regulated by the interaction of heterotrimeric G proteins with phospholipase C-␤ (PLC-␤).
The response of cells to classical growth factors and other mitogens is much more complex, with several possible pathways being activated depending on the stimulus. In most of these pathways, the signal is transmitted via sequential activation of cytoplasmic protein kinases, leading to the activation of nuclear transcription factors. Mitogen-activated protein kinase kinase (MEK) and its substrates, mitogen-activated protein kinases (MAPKs) p44 [extracellular signalregulated kinase (ERK) I] and p42 (ERKII), are recognized as central regulators of mitogenic signaling pathways in smooth muscle (14, 17, 24) . These kinases also have been identified as potential sites of cross talk between contractile and mitogenic pathways because their activation has been correlated with mitogenic effects of contractile agonists acting on G protein-coupled receptors (6, 15, 17) . The contractile effects of growth factors, on the other hand, are mediated by the ␥ isoform of PLC (PLC-␥). PLC-␥ causes an increase in [Ca 2ϩ ] i through the same sequence of events as PLC-␤ on its association with tyrosine-phosphorylated domains of growth factor receptors (21) .
Recent studies suggest that tyrosine kinases may also have a role in contractile responses evoked by agonists acting through G protein-coupled receptors (1, 2, 29, 35) . Few reports, however, have addressed the issue of mechanisms involved in this process. Studies of vascular smooth muscle indicate a possible role for MAPK (29, 34) and PLC-␥ (18) . The aim of our study was to investigate whether tyrosine kinase inhibition affects contraction of airway smooth muscle cells, and if so, whether modulation of Ca 2ϩ signaling has a role in this effect. We also wished to examine if contractile agonist-evoked changes in Ca 2ϩ signaling involved mechanisms similar to those required for mitogenic effects of contractile agonists, as well as establish which step of the contractile signal transduction pathway was affected.
MATERIALS AND METHODS
Cell culture. Tracheal smooth muscle cells from 7-to 9-wk-old male Fischer rats (Harlan Sprague Dawley; Freder-ick, MD) were cultured according to previously described methods (28) . Briefly, the cells were enzymatically dissociated with 0.05% elastase type IV and 0.2% collagenase type IV and cultured in 1:1 Dulbecco's modified Eagle's medium (DMEM)-Ham's F-12 medium supplemented with 10% fetal bovine serum (FBS), 0.224% NaHCO 3 , and 1% penicillin-streptomycin in the presence of 5% CO 2 . On reaching confluence (ϳ7 days after the culture was established) the cells were trypsinized and subcultured at a density of 5,000 cells/ml. Cells from a first or second passage were rendered quiescent by incubation in medium with 1% FBS 36-48 h before experiments. Based on our previous studies of rat airway smooth muscle proliferation, the estimated number of divisions was ϳ14-21 for first-and second-passage cells, respectively. Confirmation of a smooth muscle phenotype was based on typical morphology, positive ␣-actin staining, negative keratin staining, and contractile responses to agonists.
Measurement of cell contraction. Cells used for contraction measurements were plated on microscopy coverslips coated with rat tail collagen (12) and rendered quiescent by serum deprivation at ϳ50% confluence. The cells were labeled with a lipophilic fluorescent dye DiOC 6 (3) and incubated for 10 min with 40 µM genistein or with the appropriate vehicle. Cells were stimulated with 1 µM serotonin (5-HT) and 5 min later with 10 µM ionomycin, and images were acquired at the rate of 1 image/min using an intensified charge-coupled device camera (VideoScope) mounted on a Nikon microscope and commercial software [Photon Technology International (PTI); Princeton, NJ]. The excitation light wavelength was 490 nm and emission wavelength was 530 nm. Digitized images of unstimulated cells and maximally contracted cells were printed, and the surface area of individual cells was measured with a digitizing tablet. Three experiments were performed, with data from 29 to 36 cells recorded in each experiment.
Ca 2ϩ measurements. Cells grown on microscopy coverslips were loaded with the Ca 2ϩ -sensitive dye fura 2-acetoxymethyl ester (AM) according to previously described methods (28) . The cells were exposed to inhibitors (20-40 µM genistein, 10 µM tyrphostin, and 30 µM PD-98059) or an equivalent volume of an appropriate vehicle or control substance for 10 min (for genistein and tyrphostin 23) or 20 min (for PD-98059) before the addition of 1 µM 5-HT. Fluorescence of a small sample of cells (3) (4) (5) was recorded before and after stimulation at a single emission wavelength (510 nm) with a double excitatory wavelength (345 and 380 nm) using a PTI D401 microphotometer and PTI software. Background fluorescence measured in the presence of the inhibitors in cells not loaded with fura 2 was subtracted. The [Ca 2ϩ ] i was calculated according to the formula of Grynkiewicz et al. (8) . The dissociation constant was assumed to be 224 nM, mean R max (345-to 380-nm fluorescence ratio of calcium-saturated cells measured in cells exposed to 10 Ϫ5 M ionomycin-Hanks' buffer) was 7.6, R min (345-to 380-nm fluorescence ratio of Ca 2ϩ -free cells measured in cells exposed to 10 Ϫ5 M ionomycin and 10 Ϫ6 M EGTA in Ca 2ϩ -free buffer) was 0.55, and B (the ratio of fluorescence at 380-nm excitation wavelength in Ca 2ϩ -free and Ca 2ϩ -saturated cells) was 8.89. before stimulation with 1 µM 5-HT in the presence of the phosphatase inhibitor sodium orthovanadate (1 mM) for 10 min. To stimulate PLC-␥ phosphorylation, cells were incubated with the BB isoform of platelet-derived growth factor (PDGF) at a concentration of 10 ng/ml for 30 min in the presence of sodium orthovanadate. Cells were rinsed with ice-cold PBS with sodium orthovanadate, 1 ml of lysis buffer [1% Nonidet P-40 detergent, 20 mM Tris (pH 8.0), 137 mM NaCl, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 0.15 U aprotinin/ml, and 1 mM sodium orthovanadate] was added to each plate, and cells were scraped and left on ice for ϳ30 min. Lysates were centrifuged at 4°C for 10 min at 14,000 rpm (Eppendorf centrifuge 5402), and supernatants were stored at Ϫ80°C.
SDS-PAGE and
Protein was quantified by the method of Bradford, and each lane was loaded with equal amounts of protein (10 or 20 µg). Proteins were resolved by 7.5% SDS-PAGE (Bio-Rad PROTEAN Mini II apparatus, Bio-Rad; Mississauga, ON). The separated proteins were electroblotted onto 0.22-µm-pore nitrocellulose filters for 18 h at a constant voltage of 30 V, and the efficacy of the transfer was confirmed by Ponceau staining as well as posttransfer staining of the gel with Coomassie blue. The filters were blocked for 1 h at room temperature with 3% milk powder in Tris-buffered saline with 0.05% Tween 20, incubated for 1 h with a biotinylated monoclonal primary antibody (for phosphorylated tyrosine), followed by streptavidin-horseradish peroxidase (HRP) or a primary antibody followed by a polyclonal HRP-conjugated secondary antibody (for PLC-␥). Blots were then developed by enhanced chemiluminescence (ECL, Amersham Canada; Oakville, ON) and presented as multiples of increase over control. All quantified bands were of a density that fell within linear range as established by varying protein loading and exposure times. Molecular weights were estimated by comparison with biotinylated molecular weight standards (Bio-Rad). For reprobing with a different antibody, blots were stripped with 0.1 M glycine, pH 2.9, and the immunoblotting protocol was repeated.
Immunoprecipitation. One milliliter of cell lysate from each group (control, 5-HT stimulated, and PDGF stimulated) containing 1 mg of protein was precleared with agaroseconjugated mouse IgG, and supernatants were precipitated for 2 h with 20 µl of agarose-conjugated anti-phosphotyrosine antibody. Immunoprecipitates were washed with the lysis buffer, resuspended in Laemmli buffer, subjected to PAGE, and, after transfer to nitrocellulose filters, probed with anti-PLC-␥ antibody and HRP-conjugated secondary antibody. The bands were visualized using chemiluminescence and the FluorChem 8000 chemiluminescence imaging system (Alpha Innotech; San Leandro, CA).
Measurement of inositol phosphates. Confluent cells plated onto 60-mm-diameter dishes were growth arrested and radiolabeled for 48 h with inositol-free DMEM containing 2% FBS and 1 µCi/ml myo-[ 3 H]inositol (specific activity 17.0 Ci/mmol). Cells were washed free of unincorporated myo-[ 3 H]inositol with PBS (in mmol/l: 137 NaCl, 2.7 KCl, 8.5 Na 2 HPO 4 , 1.5 KH 2 PO 4 , 0.9 MgCl 2 , 5.5 glucose, 0.7 CaCl 2 , and 0.1% BSA) and preincubated with 10 mM LiCl in 1 ml of PBS in the presence and absence of genistein at 37°C for 10 min. The cells were challenged with 5-HT in the presence of LiCl for 10 min at 37°C. Stimulation was terminated by the addition of 100:1 vol/vol methanol-HCl. Chloroform (50 vol/vol to HCl) was added to the supernatant, and the aqueous and organic fractions were separated by centrifugation. The top aqueous layer was assayed for total myo-[ 3 H]inositol phosphate activity by anion-exchange chromatography. Samples were loaded onto columns containing 1 ml of the formate form Dowex 1-X8 Materials. DMEM, FBS, penicillin, and streptomycin were obtained from GIBCO Canada (Mississauga, ON) and Ham's F-12 from ICN. DiOC 6 (3) and fura 2-AM were purchased from Molecular Probes (Eugene, OR), and genistein, tyrphostins, and PD-98059 were from Calbiochem (LaJolla, CA). Electrophoresis reagents were obtained from Bio-Rad, rabbit polyclonal anti-PLC-␥ antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA), and monoclonal anti-PLC-␥ antibodies were from Transduction Laboratories (Lexington, KY). ECL reagents, film, HRP-conjugated anti-rabbit and anti-mouse antibodies, and myo-[ 3 H]inositol were purchased from Amersham Canada. Anti-phosphotyrosine antibodies and all remaining chemicals were purchased from Sigma (St Louis, MO).
RESULTS
The contractile effects of 5-HT were tested on cultured rat tracheal smooth muscle cells grown on rat tail collagen. 5-HT (1 µM) caused a contraction that resulted in a 10 Ϯ 1% decrease in the surface area of the cells. The subsequent application of the calcium ionophore ionomycin (10 µM) elicited a greater contraction (18 Ϯ 3% decrease in area). The tyrosine kinase inhibitor genistein at 40 µM inhibited 5-HT-induced contractions in almost all cells, with the mean surface area of the stimulated cells at 101 Ϯ 3% of the controls, but had no significant effect on contraction elicited by ionomycin in the same cells (26 Ϯ 2% decrease in surface area; Fig. 1 ).
Genistein (40 µM) also affected 5-HT-induced Ca 2ϩ transients in a concentration-dependent manner, causing a significant decrease in peak Ca 2ϩ response (from 441.7 Ϯ 59.49 nM in controls to 223.6 Ϯ 35.32 nM in genistein-treated cells, P ϭ 0.009; Fig. 2A ). The effect of tyrphostin 23, a tyrosine kinase inhibitor structurally different from genistein, was similar. At a concentration of 10 µM, it caused a decrease in 5-HT-induced Ca 2ϩ responses, with a peak Ca 2ϩ of 294.8 Ϯ 29.10 nM compared with 507.0 Ϯ 68.28 nM in the cells incubated with the inactive tyrphostin analog tyrphostin A-1, (Fig. 2B) . The effect of genistein was also observed in the absence of extracellular Ca 2ϩ , and the decrease in peak Ca 2ϩ was even greater than in Ca 2ϩ -containing medium (from 441.73 Ϯ 59.49 nM Ca 2ϩ in the controls to 97.04 Ϯ 26.55 nM Ca 2ϩ in the presence of 40 µM genistein; Fig. 2C ).
Western analysis demonstrated that 1 µM 5-HT caused an increase in tyrosine phosphorylation of proteins with approximate molecular masses of 70 and 115 kDa within 10 s after the application of the agonist application (Fig. 3A) . The increase in tyrosine phosphorylation was significantly inhibited in the cells treated with 40 µM genistein (Fig. 3B, Table 1 ). The identity of the tyrosine-phosphorylated proteins has not been established. However, we specifically examined the blots for evidence of tyrosine phosphorylation of PLC-␥, which we were not able to detect although it was apparent in the cells stimulated with PDGF (Fig. 4, A  and B) . The lack of PLC-␥ tyrosine phosphorylation caused by 5-HT was also confirmed by the absence of the PLC-␥ band in immunoprecipitates of tyrosinephosphorylated proteins from 5-HT-stimulated cells, with simultaneous detection of PLC-␥ in the lysates from PDGF-stimulated cells (Fig. 4C) .
To test the possibility that MAPKs were involved in [Ca 2ϩ ] i regulation, we used the specific inhibitor of the upstream kinase MEK, PD-98059. No significant change in peak Ca 2ϩ responses to 1 µM 5-HT was observed after 20 min of incubation with 30 µM PD-98059 (Fig. 5) .
To establish whether tyrosine kinase inhibition exerted its effects downstream or upstream of PLC, we measured 5-HT-evoked inositol phosphate production in the presence and absence of 40 µM genistein. As expected, 5-HT induced a dramatic increase in inositol phosphate production (ϳ600% of the baseline turnover in the cells stimulated with 1 µM 5-HT and 800% in the cells stimulated with 10 µM 5-HT). Inositol phosphate production induced by both concentrations of 5-HT was significantly reduced in the cells incubated with 40 µM genistein (Fig. 6) .
DISCUSSION
Although the existence of cross talk between signaling pathways mediating contractility (PLC and inositol phosphates) and growth (tyrosine kinase pathway) of vascular smooth muscle has been a subject of several studies (6, 11, 15 ; reviewed in Refs. 9 and 25), little is known about the modulation by tyrosine kinases of the signaling pathways leading to inositol phosphate production after activation of G protein-coupled receptors (7, 13, 18, 23, 35) . Indeed, to our knowledge, there are only three reports indicating a possible role for tyrosine kinases in airway smooth muscle contraction (1, 2, 33) . Our study has shown that a component of the 5-HTevoked decrease in the area of cultured rat airway smooth muscle cells is tyrosine kinase dependent. These results imply that the previously described effect of tyrosine kinase inhibition on 5-HT-induced contraction of vascular strips (35) and isolated rat bronchioles (2) reflects altered responses of smooth muscle and not an indirect effect mediated by other cell types present in these preparations. The fact that the effects on cultured smooth muscle cells parallel the effects on muscle strips also suggests that agonist-induced changes in cell area may be a manifestation of the same processes as those taking place during the contraction of the intact muscle. This is further supported by the observation that the 5-HT-induced decrease in cell area can be blocked by PLC inhibitor U-73122 (unpublished data). However, the possibility that in cultured cells signaling pathways may be altered and may be different from those in the intact muscle has not been excluded.
Altered smooth muscle contractility by inhibitors of tyrosine kinase could result from either the modulation of structural or regulatory proteins or alterations of Ca 2ϩ signaling. For example, acetylcholine-and 5-HTinduced tyrosine phosphorylation of paxillin and focal adhesion kinase, a protein and tyrosine kinase, respectively, present in dense plaques, have been described in canine tracheal smooth muscle (22, 27, 33) , suggesting that interference with cytoskeletal rearrangement might be a potential mechanism for the effects. However, our data have shown that tyrosine phosphorylation may also have an important role in the coupling of G protein-linked receptor activation to increases in [Ca 2ϩ ] i . The observation that genistein did not affect Ca 2ϩ ionophore-induced contraction suggests that in rat airway smooth muscle cells the main effect of tyrosine kinase was exerted on signaling involved in Ca 2ϩ release and not on sensitivity of the contractile apparatus to Ca 2ϩ . This conclusion is consistent with a study showing that the genistein-dependent decrease in [Ca 2ϩ ] i quantitatively accounted for the decrease in myosin light chain phosphorylation in swine carotid arteries (7) and with the observation that tyrosine kinase inhibitors did not alter increases in isometric force evoked by direct activation of the contractile apparatus by Ca 2ϩ in skinned vascular smooth muscle fibers (3). However, we observed a complete genisteininduced inhibition of cell contraction, although there was only partial inhibition of Ca 2ϩ increase and inositol phosphate production. Although this observation may be construed as indicating that tyrosine kinase may also modulate smooth muscle contractility in a Ca 2ϩ - Values are means Ϯ SE; n ϭ 4 experiments. Densitometric measurements of protein bands corresponding to ϳ70 and 115 kDa are presented as multiple of increase over control. 5-HT, serotonin. independent fashion, there are alternate explanations. We postulate that the modest contractions of the smooth muscle cells in our experimental conditions result from limitations imposed by their attachments to substratum or from phenotypical changes occurring in culture. Perhaps under these circumstances, the partial decrease in [Ca 2ϩ ] i may have been sufficient to result in an apparent complete inhibition of contraction.
There are only a few studies of the effects of tyrosine kinase inhibitors on Ca 2ϩ signaling in vascular smooth muscle, and the results are contradictory, showing a decrease of peak responses (16, 23) or no effect on peak responses (36) , a decrease of Ca 2ϩ influx (26) and of the sustained levels of the Ca 2ϩ response (16) , or an increase of the sustained phase of the Ca 2ϩ response (30) . Our observation of the inhibitory effects of genistein on Ca 2ϩ responses in Ca 2ϩ -free medium indicates that tyrosine kinases are involved in the modulation of Ca 2ϩ release from sarcoplasmic reticulum. This effect could be explained either by the modulation of IP 3 binding to its receptors, as has been postulated for T cells where tyrosine phosphorylation of IP 3 receptors has been found (10), or by modulation of PLC activity and therefore IP 3 production. The latter explanation is supported by our observation of the genistein-induced decrease of inositol phosphate production stimulated by 5-HT. This result is also consistent with the observation in vascular smooth muscle where the increase in [Ca 2ϩ ] i induced by the direct application of IP 3 was not inhibited by genistein (16) .
The mechanism of the modulation of PLC activity by tyrosine kinases is well established only for the ␥ isoform of PLC, which is activated by phosphorylation on tyrosine on binding to tyrosine-phosphorylated residues of growth factor receptors. It also has been found that in rat vascular smooth muscle PLC-␥1 is associated with the G protein-coupled angiotensin AT 1 receptor and is responsible for angiotensin-induced Ca 2ϩ signaling (18) . However, it also has been shown that tyrosine phosphorylation of PLC-␥1 is not required for tyrosine kinase-dependent increases in [Ca 2ϩ ] i resulting from stimulation of diverse G protein-coupled receptors in A10 vascular smooth muscle cells (4) . Likewise, we have not been able to detect PLC-␥ tyrosine phosphorylation in 5-HT-stimulated rat tracheal smooth muscle cells. It seems more likely, therefore, that interference with activation of PLC-␤ is responsible for the observed reduction in inositol phosphates. The 5-HT receptors on these cells have been characterized as 5-HT2c (28), typical seven-transmembrane-domain receptors coupled to G q protein, and the interaction with ␣-or ␤␥-subunits of this protein is necessary for activation of PLC-␤. An alternate mechanism for reduction in inositol phosphates is suggested by the recent finding that in mouse embryo fibroblasts expressing the M 1 muscarinic acetylcholine receptor, stimulation with carbachol resulted in tyrosine phosphorylation of the ␣-subunit of G q protein and that this phosphorylation was necessary to evoke a Ca 2ϩ signal (32) . Perhaps similar events take place in relation to the airway smooth muscle 5-HT receptor, and the inhibition of the ␣-subunit phosphorylation by genistein leads to the observed decrease of PLC activity and the consequent diminution of the Ca 2ϩ response. It is not clear at present which tyrosine kinases are involved in this process, but soluble tyrosine kinases of the src family are the most likely candidates because they may be activated by various G protein-coupled receptors, including the AT 1 receptor in vascular smooth muscle (19) .
The ERK MAPK pathway, identified as a site of cross talk between contractile and proliferative pathways, also has been implicated in tyrosine kinase modulation of the contractile response in vascular smooth muscle (34) , and it was suggested that it modifies Ca 2ϩ signaling (29) . Our experiments demonstrated a lack of effect of a specific inhibitor of MEK kinase on 5-HT-induced Ca 2ϩ transients in airway smooth muscle cells, arguing that any effects that MAPKs may have on smooth muscle contraction are Ca 2ϩ independent. This conclusion is consistent with the studies showing that vascular smooth muscle MAPK activation by agonists acting on G protein-coupled receptors lies downstream of PLC activity (5, 20, 31) .
In summary, our study shows that in airway smooth muscle enhanced protein tyrosine phosphorylation may contribute to the signaling by G protein-coupled receptors through the modulation of activity of PLC other than PLC-␥ isoform. Further studies are required to establish which tyrosine kinase(s) is/are involved and to identify the pertinent tyrosine kinase substrates.
